among patients newly diagnosed with multiple myeloma (MM), new research showed. "To date, no randomized trial has directly compared daratumumab-based maintenance therapy vs standard of care ...
Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant ...
Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible: Beerse, Belgium Thursday, Oct ...
The trial is seen as a complement to the MAIA trial, which had shown a significant overall survival benefit with daratumumab for patients with newly diagnosed multiple myeloma. Patients newly ...
Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the safety data from the phase 3 CEPHEUS trial in newly diagnosed multiple ...
Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ...
In the treatment of patients with newly diagnosed multiple myeloma (MM) who are not eligible for stem cell transplant or are transplant-deferred, adding subcutaneous daratumumab to bortezomib ...
Grandfather-of-two Bob Munro was part of the MajesTEC-2 trial to test Teclistamab and for the first time since his blood ...
During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...
A Christchurch family are considering uprooting their lives and moving to Australia to access the blood cancer drug their mum ...
Multiple myeloma can also lead to a collapsed backbone in the spine ... (what I call healing elixirs), I am now undergoing maintenance treatment with Darzalex (daratumumab). At my most recent ...
Blood cancer patients in their 40s and 50s are urging Pharmac to overhaul its funding model, saying they have potentially years of work and paying tax ahead of them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback